-transparent.png){kind=logo}
Five hundred forty-five infants weighing less than 1501 g at birth were entered into a randomized, prospective study to determine the effect of high serum levels (5 mg/dL) of vitamin E used prophylactically to try to prevent or alter the natural course of retinopathy of prematurity (ROP) and its sequel, retrolental fibroplasia (RLF). Three hundred twenty-eight infants were available for the one- to two-year eye examination. Although there was a trend (P = 0.072) toward less severe RLF among vitamin E-treated infants, the incidence of RLF was 11/162 (6.8%) in the placebo treated (P) infants, and 12/166 (7.2%) in the vitamin E-treated (E) infants. The incidences of hyperopia, myopia, anisometropia, strabismus and amblyopia were also similar in both the P and E groups.
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
March 1984,
Arizona medicine,
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
August 1984,
The Medical journal of Australia,
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
February 1988,
Pediatrics,
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
January 1988,
Nutrition reviews,
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
September 2021,
American journal of perinatology,
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
June 1985,
Pediatrics,
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
March 2007,
Eye (London, England),
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
December 2022,
Annals of medicine and surgery (2012),
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
May 1996,
Anales espanoles de pediatria,
D B Schaffer, and
L Johnson, and
G E Quinn, and
M Weston, and
F W Bowen
January 1992,
Eye (London, England),
